Latest revision as of 20:19, 27 June 2024

Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

Other interesting and helpful links can be found by clicking the link.

Chemotherapy safety standards

2020: Dillmon et al. Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards PubMed
2019: Celano et al. Safe handling of hazardous drugs: ASCO standards PubMed
2016: Neuss et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology
2010: Carrington et al. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy PubMed

Dose adjustments

2021: Griggs et al. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

2012: Griggs et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline^[1]

Antimicrobials

2013: Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline

Growth factors

2015: Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factors^[2]

Approved antineoplastics

This section contains anticancer drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound. For drugs first approved within the current or prior calendar years, the date of initial approval is also provided here.

A

B

C

D

E

Eflornithine (Iwilfin) FDA approved 2023-12-13
Elacestrant (Orserdu) FDA approved 2023-01-27
Elotuzumab (Empliciti)
Elranatamab (Elrexfio) FDA approved on 2023-08-14
Emapalumab (Gamifant)
Enasidenib (Idhifa)
Encorafenib (Braftovi)
Enfortumab vedotin (Padcev)
Ensartinib (Ensacove)
Entrectinib (Rozlytrek)
Envafolimab (Enweida)
Enzalutamide (Xtandi)
Epcoritamab (Epkinly) FDA approved 2023-05-19
Epirubicin (Ellence)
Erdafitinib (Balversa)
Eribulin (Halaven)
Erlotinib (Tarceva)
Estradiol
Estramustine (Emcyt)
Etoposide (Vepesid)
Everolimus (Afinitor)
Exemestane (Aromasin)

F

G

Gallium Ga 68 gozetotide (Locametz)
Gefitinib (Iressa)
Gemcitabine (Gemzar)
Gemtuzumab ozogamicin (Mylotarg)
Gilteritinib (Xospata)
Glasdegib (Daurismo)
Glofitamab (Columvi) FDA approved 2023-06-15
Goserelin (Zoladex)

H

I

K

Ketoconazole (Nizoral)

L

M

N

Nadofaragene firadenovec (Adstiladrin)
Naxitamab (Danyelza)
Necitumumab (Portrazza)
Nedaplatin (Aqupla)
Nelarabine (Arranon)
Neratinib (Nerlynx)
Nilotinib (Tasigna)
Nilutamide (Nilandron)
Nimotuzumab (Theraloc)
Nimustine (ACNU)
Nintedanib (Vargatef)
Niraparib (Zejula)
Niraparib and abiraterone (Akeega) FDA approved 2023-08-11
Nirogacestat (Ogsiveo) FDA approved 2023-11-27
Nivolumab (Opdivo)
Nivolumab and relatlimab (Opdualag)
Nogapendekin alfa inbakicept (Anktiva) FDA approved 2024-04-22
Non-pegylated liposomal doxorubicin (Myocet)
Norethandrolone (Nilevar)
NovoTTF-100A system (Optune)

O

P

Q

Quizartinib (Vanflyta)

R

S

T

Tabelecleucel (Ebvallo)
Tafasitamab (Monjuvi)
Tagraxofusp (Elzonris)
Talazoparib (Talzenna)
Talimogene laherparepvec (Imlygic)
Taloporfin (Laserphyrin)
Talquetamab (Talvey) FDA approved 2023-08-09
Tamibarotene (Amnoid)
Tamoxifen (Nolvadex)
Tarlatamab (Imdelltra) FDA approved 2024-05-16
Tasonermin (Beromun)
Tazemetostat (Tazverik)
Tebentafusp (Kimmtrak)
Teclistamab (Tecvayli)
Tegafur and uracil (UFT)
Tegafur, gimeracil, oteracil (Teysuno, S-1)
Temoporfin (Foscan)
Temozolomide (Temodar)
Temsirolimus (Torisel)
Teniposide (Vumon)
Tepotinib (Tepmetko)
Thalidomide (Thalomid)
Thioguanine (Tabloid)
Thiotepa (Tepadina)
Thiotepa (Thioplex)
Tirabrutinib (Velexbru)
Tisagenlecleucel (Kymriah)
Tisotumab vedotin (Tivdak)
Topotecan (Hycamtin)
Toremifene (Fareston)
Toripalimab (Loqtorzi) FDA approved 2023-10-27
Tositumomab and I-131 (Bexxar)
Tovorafenib (Ojemda) FDA approved 2024-04-23
Trabectedin (Yondelis)
Trametinib (Mekinist)
Trastuzumab (Herceptin)
- Trastuzumab-anns (Kanjinti)
- Trastuzumab-dkst (Ogivri)
- Trastuzumab-dttb (Ontruzant)
- Trastuzumab-herw (Herwenda)
- Trastuzumab-pkrb (Herzuma)
- Trastuzumab-qyyp (Trazimera)
- Trastuzumab-strf (Hercessi) FDA approved 2024-04-29
- Trastuzumab-zerc (Zercepac)
Trastuzumab and hyaluronidase (Herceptin Hylecta)
Trastuzumab deruxtecan (Enhertu)
Trastuzumab emtansine (Kadcyla)
Tremelimumab (Imjudo)
Treosulfan (Ovastat)
Trifluridine and tipiracil (Lonsurf)
Trilostane (Vetoryl)
Trimetrexate (Neutrexin)
Triptorelin (Trelstar LA)
Trofosfamide (Ixoten)
Tucatinib (Tukysa)

U

Ublituximab (Briumvi) FDA approved 2023-01-06

V

Z

Zanubrutinib (Brukinsa)
Zimberelimab (Yu Duo)
Ziv-aflibercept (Zaltrap)
- Aflibercept-jbvf (Yesafili) FDA approved 2024-05
- Aflibercept-yszy (Opuviz) FDA approved 2024-05

Discontinued antineoplastics

This section contains drugs that have had at least one formal approval in any domain (FDA, EMA, etc), but are no longer on the market. Note that it is possible that these drugs continue to be available in some limited way, such as through compassionate use programs.

A

D

E

F

L

Levamisole (Ergamisol)

M

Melphalan flufenamide (Pepaxto)

O

Olaratumab (Lartruvo)

P

S

Semustine (MeCCNU)

T

U

V

Vincristine liposomal (Marqibo)

Investigational antineoplastics

This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.

A

B

C

CARv3-TEAM-E T-cells
Catumaxomab (Removab) in US clinical trials
Cediranib (Recentin)
Cixutumumab (IMC-A12)
Coltuximab ravtansine (SAR-3419)
Crenolanib (CP-868,596)
Custirsen (OGX-011)

D

E

F

G

H

I

J

JCAR015

L

M

N

Nolatrexed (Thymitaq)

O

P

Q

Quisinostat (JNJ-26481585)

R

S

T

U

UCART19

V

Z

Supportive and other medications

This section contains supportive drugs that are either approved or investigational. Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound.

A

B

C

D

E

F

G

H

I

Ibandronate (Boniva)
Idarucizumab (Praxbind)
Indomethacin (Indocin)
Iptacopan (Fabhalta) FDA approved 2023-12-05
Iron dextran (INFeD)
Iron sucrose (Venofer)
Itraconazole (Sporanox)

L

Lactulose
Lamivudine (Epivir)
Lansoprazole (Prevacid)
Lenograstim (Granocyte)
Lepirudin (Refludan) discontinued
Letermovir (Prevymis)
Levofloxacin (Levaquin)
L-glutamine (Endari)
Lipefilgrastim (Lonquex)
Loperamide (Imodium)
Lorazepam (Ativan)
Lovotibeglogene autotemcel (Lyfgenia) FDA approved on 2023-12-08
Luspatercept (Reblozyl)
Lusutrombopag (Mulpleta)

M

Mannitol
Meperidine (Demerol)
Mesna (Mesnex)
Methyltesterone (Android)
Metoclopramide (Reglan)
Mitapivat (Pyrukynd)
Motixafortide (Aphexda) FDA approved 2023-09
Mycophenolate mofetil (CellCept)

N

O

Olanzapine (Zyprexa)
Omeprazole (Prilosec)
Omidubicel (Omisirge) FDA approved 2023-04-17
Ondansetron (Zofran)
Oprelvekin (Neumega)

P

Q

Quinine (Qualaquin)

R

S

T

U

V

W

Warfarin (Coumadin)

Z

Zoledronic acid (Zometa)

By Category

Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is an ongoing process so not all of these links are active or current).

Drugs in a REMS program

Cytotoxic Chemotherapy

Kinase inhibitors

Endocrine therapy

Investigational and Discontinued

Biologics

Miscellaneous

Medications by Condition

Medications by Route of Administration

Medications by FDA Year of Approval

Interesting and Helpful Links

Antidepressants and other psychiatric medications in cancer care
Antiemetic support
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline (2013)
2016 Updated American Society of Clinical Oncology/Oncology Nursing Society (ASCO/ONS) Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology
Chemotherapy Administration Sequence^[3] - with chemotherapy sequencing chart
The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. PubMed
CredibleMeds.org - lists of QT-prolonging drugs; requires free registration to see full list
FDA drug shortages list
ASHP drug shortages list - also includes information about discontinued drugs
DailyMed - a comprehensive NLM portal to all FDA-approved drugs
Drugs@FDA - the main portal into the FDA drug database
The NCI Drug Dictionary - an extensive resource with most antineoplastics (approved and in clinical trials) listed
In the Pipeline - a blog from a veteran of the pharmaceutical industry, Derek Lowe. General but much is cancer-relevant. The old home of this blog is no longer active.
Steroid conversions
Vesicant & irritant chemotherapy
Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers
CPIC Guidelines The Clinical Pharmacogenetics Implementation Consortium provides guidelines for a small set of drugs with pharmacogenetically-guided dosing implications, some of which are oncologics

References

↑ Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed
↑ Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13. link to original article PubMed
↑ Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article

[1] Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed

[2] Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13. link to original article PubMed

[3] Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article

[1]

[2]

[3]

@@ Line 1: / Line 1: @@
+<span id="BackToTop"></span>
+<div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px; opacity:0.8; border-style: solid; border-color:DarkGray; border-width: 1px">
+[[#top|Back to Top]]
+</div>
+=Guidelines=
+'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.'''
-=Guidelines=
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 '''Other [[#Interesting_and_Helpful_Links|interesting and helpful links]] can be found by clicking the link.'''
 ==Chemotherapy safety standards==
-*'''2016:''' [http://ascopubs.org/doi/full/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology]
-*'''2010:''' [https://onlinelibrary.wiley.com/doi/10.1111/j.1743-7563.2010.01321.x/full The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.] [https://www.ncbi.nlm.nih.gov/pubmed/20887505 PubMed]
+*'''2020:''' Dillmon et al. [https://doi.org/10.1200/JCO.19.02297 Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards] [https://pubmed.ncbi.nlm.nih.gov/31815576/ PubMed]
+*'''2019:''' Celano et al. [https://doi.org/10.1200/JCO.18.01616 Safe handling of hazardous drugs: ASCO standards] [https://pubmed.ncbi.nlm.nih.gov/30620670/ PubMed]
+*'''2016:''' Neuss et al. [https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology]
+*'''2010:''' Carrington et al. [https://doi.org/10.1111/j.1743-7563.2010.01321.x The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy] [https://pubmed.ncbi.nlm.nih.gov/20887505/ PubMed]
 ==Dose adjustments==
-*'''2012:''' [http://jco.ascopubs.org/content/30/13/1553.long Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [http://jco.ascopubs.org/content/30/13/1553.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/22473167 PubMed]</ref>
+*'''2021:''' Griggs et al. [https://doi.org/10.1200/jco.21.00471 Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update]
+*'''2012:''' Griggs et al. [https://doi.org/10.1200/jco.2011.39.9436 Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [https://doi.org/10.1200/jco.2011.39.9436 link to original article] [https://pubmed.ncbi.nlm.nih.gov/22473167/ PubMed]</ref>
 ==Antimicrobials==
-*'''2013:''' [http://ascopubs.org/doi/full/10.1200/JCO.2012.45.8661 Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline]
+*'''2013:''' [https://doi.org/10.1200/JCO.2012.45.8661 Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline]
 ==Growth factors==
-*'''2015:''' [http://jco.ascopubs.org/content/33/28/3199.full Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factors]<ref>Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.</ref>
-=Alphabetically=
+*'''2015:''' [https://doi.org/10.1200/jco.2015.62.3488 Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factors]<ref>Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13. [https://doi.org/10.1200/jco.2015.62.3488 link to original article] [https://pubmed.ncbi.nlm.nih.gov/26169616/ PubMed]</ref>
+=Approved antineoplastics=
+''This section contains anticancer drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound. For drugs first approved within the current or prior calendar years, the date of initial approval is also provided here.''
 ==A==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
+*[[Abarelix (Plenaxis)]]
-|[[#top|back to top]]
+*[[Abemaciclib (Verzenio)]]
-|}
-*[[Abciximab (ReoPro)]]
-*[[Abemaciclib (Verzenio)]] '''FDA approved 9/28/2017'''
-*[[Abexinostat (PCI-24781)]] '''in clinical trials'''
 *[[Abiraterone (Zytiga)]]
-*[[Acalabrutinib (Calquence)]] '''FDA approved 10/31/2017'''
+*[[Acalabrutinib (Calquence)]]
-*[[Acetaminophen (Tylenol)]]
 *[[Aclarubicin (Aclacinomycin)]]
-*[[Actinium Ac 225 lintuzumab (Actimab-A)]] '''in clinical trials'''
+*[[Adagrasib (Krazati)]]
-*[[Acyclovir (Zovirax)]]
-*[[Adenovirus-interferon-γ (TG1042)]] '''in clinical trials'''
-*[[Ado-trastuzumab emtansine (Kadcyla)]]
 *[[Afatinib (Gilotrif)]]
-*[[Afuresertib (GSK2110183)]] '''in clinical trials'''
 *[[Aldesleukin (Proleukin)]]
 *[[Alectinib (Alecensa)]]
 *[[Alemtuzumab (Campath)]]
-*[[Alendronate (Fosamax)]]
+*[[Alitretinoin (Panretin)]]
-*[[Alisertib (MLN8237)]] '''in clinical trials'''
 *[[All-trans retinoic acid (ATRA)]]
-*[[Allopurinol (Zyloprim)]]
+*[[Alpelisib (Piqray)]]
-*[[Alprazolam (Xanax)]]
 *[[Altretamine (Hexalen)]]
 *[[Alvocidib (Flavopiridol)]]
-*[[Amatuximab (MORAb-009)]] '''in clinical trials'''
-*[[AMG 330]] '''in clinical trials'''
 *[[Amifostine (Ethyol)]]
-*[[Aminocaproic acid (Amicar)]]
 *[[Aminoglutethimide (Cytadren)]]
-*[[Aminopterin]]
+*[[Amivantamab (Rybrevant)]]
-*[[Amonafide (Quinamed)]] '''in clinical trials'''
 *[[Amrubicin (Calsed)]]
 *[[Amsacrine (Amsidine)]]
-*[[Anagrelide (Agrylin)]]
+*[[Anastrozole (Arimidex)]]
-*[[Anastrozole (Arimidex)]]
 *[[Ancestim (Stemgen)]]
-*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
+*[[Anlotinib (Fukewei)]]
-*[[Antithrombin III (human and recombinant)]]
+*[[Apalutamide (Erleada)]]
-*[[Antithymocyte globulin, horse ATG (Atgam)]]
-*[[Antithymocyte globulin, rabbit ATG (Grafalon)]]
-*[[Antithymocyte globulin, rabbit ATG (Thymoglobulin)]]
-*[[Apalutamide (Erleada)]] '''FDA approved 2/14/2018'''
 *[[Apatinib (Aitan)]]
-*[[Apixaban (Eliquis)]]
-*[[Apocept (APG101)]] '''in clinical trials'''
-*[[Aprepitant (Emend)]]
-*[[Argatroban (Acova)]]
 *[[Arsenic trioxide (Trisenox)]]
-*[[Ascorbic acid (Vitamin C)]]
+*[[Asciminib (Scemblix)]]
-*[[Asparaginase (Elspar)]] '''discontinued'''
 *[[Asparaginase Erwinia chrysanthemi (Erwinaze)]]
-*[[Aspirin]]
+**[[Asparaginase erwinia chrysanthemi-rywn (Rylaze)]]
-*[[Aspirin and dipyridamole (Aggrenox)]]
+*[[Atezolizumab (Tecentriq)]]
-*[[Astuprotimut-R (GSK1572932A)]] '''in clinical trials'''
+*[[Aumolertinib (Amelie)]]
-*[[Atezolizumab (Tecentriq)]]
+*[[Avapritinib (Ayvakit)]]
-*[[Atropine (Atropen)]]
+*[[Avelumab (Bavencio)]]
-*[[Atovaquone (Mepron)]]
+*[[Axicabtagene ciloleucel (Yescarta)]]
-*[[Avatrombopag (Doptelet)]] '''FDA approved 5/21/2018'''
-*[[Avelumab (Bavencio)]] '''FDA approved 3/23/2017'''
-*[[Axicabtagene ciloleucel (Yescarta)]] '''FDA approved 10/18/2017'''
 *[[Axitinib (Inlyta)]]
+*[[Azacitidine (Onureg)]]
 *[[Azacitidine (Vidaza)]]
-*[[AZD5363]] '''in clinical trials'''
 ==B==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
+*[[BCG vaccine]]
-|}
+*[[Belantamab mafodotin (Blenrep)]]
-*[[Bacillus Calmette-Guerin (BCG)]]
-*[[Barasertib (AZD1152)]] '''in clinical trials'''
-*[[Bavituximab (PGN401)]] '''in clinical trials'''
-*[[Belagenpumatucel-L (Lucanix)]] '''in clinical trials'''
 *[[Belinostat (Beleodaq)]]
 *[[Belotecan (Camptobell)]]
+*[[Belumosudil (Rezurock)]]
+*[[Belzutifan (Welireg)]]
 *[[Bendamustine]]
-*[[Betrixaban (Bevyxxa)]] '''FDA approved on 6/23/2017'''
+*[[Benralizumab (Fasenra)]]
 *[[Bevacizumab (Avastin)]]
-*[[Bevacizumab-awwb (Mvasi)]] '''FDA approved on 9/14/2017'''
+**[[Bevacizumab-adcd (Vegzelga)]]
+**[[Bevacizumab-aveg (Avegra)]]
+**[[Bevacizumab-awwb (Mvasi)]]
+**[[Bevacizumab-aybi (Aybintio)]]
+**[[Bevacizumab-bvzr (Zirabev)]]
+**[[Bevacizumab-equi (Equidacent)]]
+**[[Bevacizumab-maly (Alymsys)]]
+**[[Bevacizumab-onbe (Onbevzi)]]
+**[[Bevacizumab-tnjn (Avzivi)]] '''FDA approved 2023-12'''
 *[[Bexarotene (Targretin)]]
 *[[Bicalutamide (Casodex)]]
-*[[Binimetinib  (MEK162)]] '''in clinical trials'''
+*[[Binimetinib (Mektovi)]]
-*[[Bivalirudin (Angiomax)]]
-*[[BHQ880]] '''in clinical trials'''
-*[[BL22 immunotoxin (CAT-3888)]] '''in clinical trials'''
 *[[Bleomycin (Blenoxane)]]
 *[[Blinatumomab (Blincyto)]]
+*[[Borofalan-10B (Steboronine)]]
 *[[Bortezomib (Velcade)]]
 *[[Bosutinib (Bosulif)]]
 *[[Brentuximab vedotin (Adcetris)]]
-*[[Brigatinib (Alunbrig)]] '''FDA approved on 4/28/2017'''
+*[[Brexucabtagene autoleucel (Tecartus)]]
-*[[Buparlisib (BKM120)]] '''in clinical trials'''
+*[[Brigatinib (Alunbrig)]]
 *[[Buserelin (Suprefact)]]
 *[[Busulfan (Myleran)]]
 ==C==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[Cabazitaxel (Jevtana)]]
 *[[Cabozantinib (Cabometyx)]]
 *[[Cabozantinib (Cometriq)]]
-*[[Calcium phosphate rinse (Caphosol)]]
+*[[Calaspargase (Asparlas)]]
-*[[Cangrelor (Kengreal)]]
+*[[Camrelizumab (AiRuiKa)]]
 *[[Capecitabine (Xeloda)]]
-*[[Caplacizumab (ALX-0081)]] '''in clinical trials'''
+*[[Capivasertib (Truqap)]] '''FDA approved 2023-11-16'''
+*[[Caplacizumab (Cablivi)]]
+*[[Capmatinib (Tabrecta)]]
 *[[Carboplatin (Paraplatin)]]
 *[[Carfilzomib (Kyprolis)]]
-*[[Carmustine (BiCNU)]]
+*[[Carmofur (HCFU)]]
+*[[Carmustine (BCNU)]]
 *[[Carmustine wafer, polifeprosan 20 (Gliadel)]]
-*[[Caspofungin (Cancidas)]]
+*[[Cemiplimab (Libtayo)]]
-*[[Catumaxomab (Removab)]] '''in US clinical trials'''
-*[[CC-292 (AVL-292)]] '''in clinical trials'''
-*[[Cediranib (Recentin)]] '''in clinical trials'''
-*[[Cemiplimab (Libtayo)]] '''FDA approved 9/28/2018'''
 *[[Ceritinib (Zykadia)]]
-*[[Cetirizine (Zyrtec)]]
 *[[Cetuximab (Erbitux)]]
 *[[Chidamide (Epidaza)]]
 *[[Chlorambucil (Leukeran)]]
-*[[Chlorpheniramine (Chlor-Trimeton)]]
+*[[Chlorozotocin (DCNU)]]
-*[[Cilostazol (Pletal)]]
+*[[Ciltacabtagene autoleucel (Carvykti)]]
-*[[Cimetidine (Tagamet)]]
-*[[Ciprofloxacin (Cipro)]]
 *[[Cisplatin (Platinol)]]
-*[[Cixutumumab (IMC-A12)]] '''in clinical trials'''
 *[[Cladribine (Leustatin)]]
-*[[Clarithromycin (Biaxin)]]
-*[[Clemastine (Tavist)]]
-*[[Clodronate (Bonefos)]]
 *[[Clofarabine (Clolar)]]
-*[[Clopidogrel (Plavix)]]
 *[[Cobimetinib (Cotellic)]]
-*[[Coltuximab ravtansine (CoR, SAR3419)]] '''in clinical trials'''
+*[[Copanlisib (Aliqopa)]]
-*[[Copanlisib (Aliqopa)]] '''FDA approved on 9/14/2017'''
+*[[Cortisone]]
-*[[Crenolanib (CP-868,596)]] '''in clinical trials'''
-*[[Crizanlizumab (SEG101)]] '''in clinical trials'''
 *[[Crizotinib (Xalkori)]]
-*[[Custirsen (OGX-011)]] '''in clinical trials'''
-*[[Cyanocobalamin (Vitamin B12)]]
 *[[Cyclophosphamide (Cytoxan)]]
-*[[Cyclosporine modified (Neoral)]]
+*[[Cyproterone acetate (Androcur)]]
-*[[Cyclosporine non-modified (Sandimmune)]]
+*[[Cytarabine (Ara-C)]]
-*[[Cytarabine (Cytosar)]]
+*[[Cytarabine and daunorubicin liposomal (Vyxeos)]]
-*[[Cytarabine and daunorubicin liposomal (Vyxeos)]] '''FDA approved on 8/3/2017'''
 *[[Cytarabine liposomal (DepoCyt)]]
-*[[Cytomegalovirus Immune Globulin (Cytogam)]]
 ==D==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
-*[[Dabigatran (Pradaxa)]]
 *[[Dabrafenib (Tafinlar)]]
 *[[Dacarbazine (DTIC)]]
-*[[Dacomitinib (Vizimpro)]] '''FDA approved 9/27/2018'''
+*[[Dacomitinib (Vizimpro)]]
 *[[Dactinomycin (Cosmegen)]]
-*[[Dalteparin (Fragmin)]]
-*[[Danazol (Danocrine)]]
-*[[Dapsone (Aczone)]]
 *[[Daratumumab (Darzalex)]]
-*[[Darbepoetin alfa (Aranesp)]]
+*[[Daratumumab and hyaluronidase (Darzalex Faspro)]]
-*[[Darolutamide (ODM-201)]] '''in clinical trials'''
+*[[Daratumumab and vorhyaluronidase (Darzquro)]]
+*[[Darinaparsin (Darvias)]]
+*[[Darolutamide (Nubeqa)]]
 *[[Dasatinib (Sprycel)]]
 *[[Daunorubicin (Cerubidine)]]
-*[[Daunorubicin liposomal (DaunoXome)]]
 *[[Decitabine (Dacogen)]]
-*[[Deferasirox (Exjade)]]
+*[[Decitabine and cedazuridine (Inqovi)]]
-*[[Deferasirox (Jadenu)]]
-*[[Deferiprone (Ferriprox)]]
-*[[Deferoxamine (Desferal)]]
-*[[Defibrotide (Defitelio)]]
 *[[Degarelix (Firmagon)]]
-*[[Denileukin diftitox (Ontak)]]
-*[[Denosumab (Xgeva)]]
-*[[Desmopressin (DDAVP)]]
 *[[Dexamethasone (Decadron)]]
-*[[Dexchlorpheniramine (Polaramine)]]
-*[[Dexrazoxane (Zinecard)]]
-*[[Diethylstilbestrol (DES)]]
-*[[Dinaciclib (SCH 727965)]] '''in clinical trials'''
 *[[Dinutuximab (Unituxin)]]
-*[[Diphenhydramine (Benadryl)]]
+*[[Dinutuximab beta (Qarziba)]]
-*[[Dipyridamole (Persantine)]]
-*[[Discodermolide (XAA296)]] '''in clinical trials'''
-*[[DMUC5754A]] '''in clinical trials'''
 *[[Docetaxel (Taxotere)]]
-*[[Docusate (Colace)]]
+*[[Donafenib (Zepsun)]]
-*[[Dolasetron (Anzemet)]]
+*[[Dostarlimab (Jemperli)]]
-*[[Domperidone (Motilium)]]
+*[[Doxifluridine (Didox)]]
-*[[Dovitinib (TKI-258)]] '''in clinical trials'''
 *[[Doxorubicin (Adriamycin)]]
-*[[Pegylated liposomal doxorubicin (Doxil)]]
+*[[Durvalumab (Imfinzi)]]
-*[[Dronabinol (Marinol)]]
-*[[Durvalumab (Imfinzi)]] '''FDA approved 5/1/2017'''
 *[[Dutasteride (Avodart)]]
-*[[Duvelisib (Copiktra)]] '''FDA approved 9/24/2018'''
+*[[Duvelisib (Copiktra)]]
 ==E==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Eflornithine (Iwilfin)]] '''FDA approved 2023-12-13'''
-|-
+*[[Elacestrant (Orserdu)]] '''FDA approved 2023-01-27'''
-|[[#top|back to top]]
-|}
-*[[Eculizumab (Soliris)]]
-*[[Edoxaban (Savaysa)]]
 *[[Elotuzumab (Empliciti)]]
-*[[Eltrombopag (Promacta)]]
+*[[Elranatamab (Elrexfio)]] '''FDA approved on 2023-08-14'''
-*[[Emicizumab-kxwh (Hemlibra)]] '''FDA approved 11/16/2017'''
+*[[Emapalumab (Gamifant)]]
-*[[Emepepimut-S (Stimuvax)]] '''in clinical trials'''
+*[[Enasidenib (Idhifa)]]
-*[[Enasidenib (Idhifa)]] '''FDA approved 8/1/2017'''
+*[[Encorafenib (Braftovi)]]
-*[[Encorafenib (LGX818)]] '''in clinical trials'''
+*[[Enfortumab vedotin (Padcev)]]
-*[[Enoxaparin (Lovenox)]]
+*[[Ensartinib (Ensacove)]]
-*[[Ensartinib (X-396)]] '''in clinical trials'''
+*[[Entrectinib (Rozlytrek)]]
-*[[Entinostat (SNDX-275)]] '''in clinical trials'''
+*[[Envafolimab (Enweida)]]
-*[[Entospletinib (GS-9973)]] '''in clinical trials'''
-*[[Entrectinib (RXDX-101)]] '''in clinical trials'''
 *[[Enzalutamide (Xtandi)]]
+*[[Epcoritamab (Epkinly)]] '''FDA approved 2023-05-19'''
 *[[Epirubicin (Ellence)]]
-*[[Epoetin alfa (Procrit)]]
+*[[Erdafitinib (Balversa)]]
-*[[Epoetin alfa-epbx (Retacrit)]] '''FDA approved 5/15/2018'''
-*[[Epratuzumab (humanised anti-CD22 antibody)]] '''in clinical trials'''
-*[[Eptifibatide (Integrilin)]]
 *[[Eribulin (Halaven)]]
 *[[Erlotinib (Tarceva)]]
+*[[Estradiol]]
 *[[Estramustine (Emcyt)]]
-*[[Etirinotecan pegol (NKTR-102)]] '''in clinical trials'''
 *[[Etoposide (Vepesid)]]
 *[[Everolimus (Afinitor)]]
@@ Line 258: / Line 195: @@
 ==F==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Fadrozole (Afema)]]
-|-
+*[[Fedratinib (Inrebic)]]
-|[[#top|back to top]]
-|}
-*[[Factor VIIa, recombinant (NovoSeven RT)]]
-*[[Factor VIII, human]]
-*[[Factor VIII, recombinant]]
-*[[Factor IX, human]]
-*[[Factor IX, recombinant]]
-*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
-*[[Factor X, human (Coagadex)]]
-*[[Factor Xa, recombinant, inactivated-zhzo (Andexxa)]] '''FDA approved 5/4/2018'''
-*[[Factor XIII concentrate, human (Corifact)]]
-*[[Famciclovir (Famvir)]]
-*[[Famotidine (Pepcid)]]
-*[[Ferric carboxymaltose (Injectafer)]]
-*[[Ferric gluconate (Ferrlecit)]]
-*[[Ferrous sulfate (Feosol)]]
-*[[Ferumoxytol (Feraheme)]]
-*[[Fibrinogen concentrate, human (RiaSTAP)]]
-*[[Filanesib (ARRY-520)]] '''in clinical trials'''
-*[[Filgrastim (Neupogen)]]
-*[[Filgrastim-sndz (Zarxio)]]
-*[[Finasteride (Proscar)]]
 *[[Fluorouracil (5-FU)]]
-*[[Floxuridine (FUDR)]]
-*[[Fluconazole (Diflucan)]]
 *[[Fludarabine (Fludara)]]
-*[[Fluoxymesterone (Halotestin)]]
+*[[Flumatinib (Xinfu)]]
 *[[Flutamide (Eulexin)]]
-*[[Folinic acid (Leucovorin)]]
+*[[Leucovorin (Folinic acid)]]
-*[[Fondaparinux (Arixtra)]]
+*[[Forodesine (Fodosine)]]
-*[[Forodesine (Fodosine)]] '''in clinical trials'''
+*[[Fostamatinib (Tavalisse)]]
-*[[Fosaprepitant (Emend for Injection)]]
+*[[Fotemustine (Muphoran)]]
-*[[Fostamatinib (Tavalisse)]] '''FDA approved 4/17/2018'''
+*[[Fruquintinib (Elunate)]]
-*[[Fotemustine (Muphoran)]] '''in clinical trials'''
-*[[Fruquintinib (HMPL-013)]] '''in clinical trials'''
 *[[Fulvestrant (Faslodex)]]
-*[[Furosemide (Lasix)]]
+*[[Furmonertinib (Ivesa)]]
+*[[Futibatinib (Lytgobi)]]
 ==G==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
+*[[Gallium Ga 68 gozetotide (Locametz)]]
-|}
-*[[Galeterone (TOK-001)]] '''in clinical trials'''
-*[[Galunisertib (LY2157299)]] '''in clinical trials'''
-*[[Ganetespib (STA-9090)]] '''in clinical trials'''
-*[[Ganitumab (AMG 479)]] '''in clinical trials'''
 *[[Gefitinib (Iressa)]]
 *[[Gemcitabine (Gemzar)]]
-*[[Gemcitabine elaidate (CP-4126, CO-101)]] '''in clinical trials'''
+*[[Gemtuzumab ozogamicin (Mylotarg)]]
-*[[Gemtuzumab ozogamicin (Mylotarg)]] '''FDA approved 9/1/17'''
+*[[Gilteritinib (Xospata)]]
-*[[Gilteritinib (ASP2215)]] '''in clinical trials'''
+*[[Glasdegib (Daurismo)]]
-*[[Glembatumumab vedotin (CDX-011)]]] '''in clinical trials'''
+*[[Glofitamab (Columvi)]] '''FDA approved 2023-06-15'''
-*[[Glucarpidase (Voraxaze)]]
 *[[Goserelin (Zoladex)]]
-*[[Granisetron (Kytril)]]
-*[[Granisetron (Sancuso)]]
-*[[Granisetron (Sustol)]]
-*[[Guadecitabine (SGI-110)]] '''in clinical trials'''
 ==H==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Heptaplatin (SunPla)]]
-|-
+*[[Histamine dihydrochloride (Ceplene)]]
-|[[#top|back to top]]
-|}
-*[[Haloperidol (Haldol)]]
-*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
-*[[Heparin]]
-*[[Heptaplatin (Sunpla)]]
-*[[HER2 peptide vaccine (AE37)]] '''in clinical trials'''
 *[[Histrelin (Vantas)]]
 *[[Hydrocortisone (Cortef)]]
@@ Line 335: / Line 230: @@
 ==I==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
-*[[Ibandronate (Boniva)]]
 *[[Ibritumomab tiuxetan (Zevalin)]]
 *[[Ibrutinib (Imbruvica)]]
 *[[Icotinib (Conmana)]]
 *[[Idarubicin (Idamycin)]]
-*[[Idarucizumab (Praxbind)]]
+*[[Idecabtagene vicleucel (Abecma)]]
 *[[Idelalisib (Zydelig)]]
 *[[Ifosfamide (Ifex)]]
-*[[IMA901]] '''in clinical trials'''
 *[[Imatinib (Gleevec)]]
-*[[Imetelstat (GRN163L)]] '''in clinical trials'''
+*[[Imetelstat (Rytelo)]] '''FDA approved 2024-06-06'''
-*[[Indatuximab ravtansine (BT062)]] '''in clinical trials'''
+*[[Infigratinib (Truseltiq)]]
-*[[Inotuzumab ozogamicin (Besponsa)]] '''FDA approved on 8/17/2017'''
+*[[Inotuzumab ozogamicin (Besponsa)]]
 *[[Interferon alfa-2a (Roferon-A)]]
 *[[Interferon alfa-2b (Intron-A)]]
-*[[Iobenguane I 131 (Azedra)]] '''FDA approved on 7/30/2018'''
+*[[Interferon gamma-1a (Imunomax-γ)]]
-*[[Ipatasertib (GDC-0068)]] '''in clinical trials'''
+*[[Interferon gamma-1b (Actimmune)]]
-*[[IPH 2101]] '''in clinical trials'''
+*[[Iobenguane I 131 (Azedra)]]
+*[[Iodine-131]]
 *[[Ipilimumab (Yervoy)]]
 *[[Irinotecan (Camptosar)]]
 *[[Irinotecan liposome (Onivyde)]]
-*[[Iron dextran (INFeD)]]
+*[[Isatuximab (Sarclisa)]]
-*[[Iron sucrose (Venofer)]]
-*[[Isatuximab (SAR-650984)]] '''in clinical trials'''
 *[[Isotretinoin (Accutane)]]
-*[[Itraconazole (Sporanox)]]
+*[[Ivosidenib (Tibsovo)]]
-*[[Ivosidenib (Tibsovo)]] '''FDA approved on 7/20/2018'''
 *[[Ixabepilone (Ixempra)]]
 *[[Ixazomib (Ninlaro)]]
-==J==
+==K==
-*[[JCAR015]] '''in clinical trials'''
-==K==
 *[[Ketoconazole (Nizoral)]]
 ==L==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
-*[[Lactulose]]
-*[[Lamivudine (Epivir)]]
 *[[Lanreotide (Somatuline)]]
-*[[Lansoprazole (Prevacid)]]
+*[[Lanreotide LAR (Somatuline Depot)]]
 *[[Lapatinib (Tykerb)]]
-*[[Lapuleucel-T (DN24-02)]] '''in clinical trials'''
+*[[Larotrectinib (Vitrakvi)]]
-*[[Larotrectinib (LOXO-101)]] '''in clinical trials'''
+*[[Lasofoxifene (Fablyn)]]
-*[[Lasofoxifene (Fablyn)]] '''not FDA approved'''
 *[[Lenalidomide (Revlimid)]]
-*[[Lenograstim (Granocyte)]]
 *[[Lenvatinib (Lenvima)]]
-*[[Lepirudin (Refludan)]] '''discontinued'''
-*[[Lestaurtinib (CEP-701)]] '''in clinical trials'''
-*[[Letermovir (Prevymis)]] '''FDA approved 11/9/2017'''
 *[[Letrozole (Femara)]]
 *[[Leuprolide (Lupron)]]
-*[[Levamisole (Ergamisol)]]
-*[[Levofloxacin (Levaquin)]]
 *[[Levoleucovorin (Fusilev)]]
-*[[L-glutamine (Endari)]] '''FDA approved 7/7/2017'''
+*[[Lifileuecel (Contego)]] '''FDA approved 2024-02-16'''
-*[[Linifanib (ABT-869)]] '''in clinical trials'''
+*[[Lisocabtagene maraleucel (Breyanzi)]]
-*[[Linsitinib (OSI-906)]] '''in clinical trials'''
+*[[Lobaplatin (D-19466)]]
-*[[Lipefilgrastim (XM22)]] '''in clinical trials'''
+*[[Lomustine (CCNU)]]
-*[[Lobaplatin]]
+*[[Loncastuximab tesirine (Zynlonta)]]
-*[[Lomustine (Ceenu)]]
+*[[Lorlatinib (Lorbrena)]]
-*[[Loperamide (Imodium)]]
+*[[Lurbinectedin (Zepzelca)]]
-*[[Lorazepam (Ativan)]]
+*[[Lutetium Lu 177 dotatate (Lutathera)]]
-*[[Lorlatinib (PF-06463922)]] '''in clinical trials'''
+*[[Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)]]
-*[[Lorvotuzumab mertansine (BB-10901)]] '''in clinical trials'''
-*[[Lusutrombopag (Mulpleta)]] '''FDA approved 7/31/2018'''
-*[[Lutetium Lu 177 dotatate (Lutathera)]] '''FDA approved 1/26/2018'''
-*[[LY3023414]] '''in clinical trials'''
 ==M==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
+*[[Margetuximab (Margenza)]]
-|[[#top|back to top]]
-|}
-*[[Mannitol]]
-*[[Mapatumumab (HGS-ETR1)]] '''in clinical trials'''
-*[[Masitinib (AB1010)]] '''in clinical trials'''
 *[[Mechlorethamine (Mustargen)]]
 *[[Medroxyprogesterone acetate (MPA)]]
-*[[Megestrol acetate (Megace)]]
+*[[Megestrol (Megace)]]
 *[[Melphalan (Alkeran)]]
+*[[Melphalan for Injection-Hepatic Delivery System (Hepzato Kit)]] '''FDA approved on 2023-08-14'''
 *[[Mepolizumab (Nucala)]]
-*[[Mercaptopurine (Purinethol)]]
+*[[Mercaptopurine (6-MP)]]
-*[[Mesna (Mesnex)]]
 *[[Methotrexate (MTX)]]
 *[[Methoxsalen (Uvadex)]]
 *[[Methylprednisolone (Solumedrol)]]
-*[[Metoclopramide (Reglan)]]
+*[[Midostaurin (Rydapt)]]
-*[[Midostaurin (Rydapt)]] '''FDA approved 4/28/2017'''
 *[[Mifamurtide (Mepact)]]
-*[[Milataxel (TL139)]] '''in clinical trials'''
+*[[Miriplatin (Miripla)]]
-*[[Mirvetuximab soravtansine (IMGN853)]] '''in clinical trials'''
+*[[Mirvetuximab soravtansine (Elahere)]]
+*[[Mitomycin pyelocalyceal (Jelmyto)]]
 *[[Mitomycin (Mutamycin)]]
 *[[Mitotane (Lysodren)]]
 *[[Mitoxantrone (Novantrone)]]
-*[[MK2206]] '''in clinical trials'''
+*[[Mobocertinib (Exkivity)]]
-*[[Mocetinostat (MGCD0103)]] '''in clinical trials'''
+*[[Mogamulizumab (Poteligeo)]]
-*[[Mogamulizumab (Poteligeo)]] '''FDA approved 8/8/2018'''
+*[[Momelotinib (Ojjaara)]] '''FDA approved 2023-09-15'''
-*[[Momelotinib (CYT387)]] '''in clinical trials'''
+*[[Mosunetuzumab (Lunsumio)]]
-*[[MOR202]] '''in clinical trials'''
+*[[Moxetumomab pasudotox (Lumoxiti)]]
-*[[MOR208]] '''in clinical trials'''
-*[[Motesanib (AMG 706)]] '''in clinical trials'''
-*[[Moxetumomab pasudotox (Lumoxiti)]] '''FDA approved 9/13/2018'''
-*[[Mycophenolate mofetil (CellCept)]]
 ==N==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Nadofaragene firadenovec (Adstiladrin)]]
-|-
+*[[Naxitamab (Danyelza)]]
-|[[#top|back to top]]
-|}
-*[[Nabilone (Cesamet)]]
 *[[Necitumumab (Portrazza)]]
 *[[Nedaplatin (Aqupla)]]
 *[[Nelarabine (Arranon)]]
-*[[NEOD001]] '''in clinical trials'''
+*[[Neratinib (Nerlynx)]]
-*[[Neratinib (Nerlynx)]] '''FDA approved 7/17/2017'''
-*[[Netupitant and palonosetron (Akynzeo)]]
 *[[Nilotinib (Tasigna)]]
 *[[Nilutamide (Nilandron)]]
-*[[Nintedanib (BIBF 1120)]] '''in clinical trials'''
+*[[Nimotuzumab (Theraloc)]]
-*[[Niraparib (Zejula)]] '''FDA approved 3/27/2017'''
+*[[Nimustine (ACNU)]]
+*[[Nintedanib (Vargatef)]]
+*[[Niraparib (Zejula)]]
+*[[Niraparib and abiraterone (Akeega)]] '''FDA approved 2023-08-11'''
+*[[Nirogacestat (Ogsiveo)]] '''FDA approved 2023-11-27'''
 *[[Nivolumab (Opdivo)]]
-*[[Nolatrexed (Thymitaq)]]
+*[[Nivolumab and relatlimab (Opdualag)]]
+*[[Nogapendekin alfa inbakicept (Anktiva)]] '''FDA approved 2024-04-22'''
 *[[Non-pegylated liposomal doxorubicin (Myocet)]]
+*[[Norethandrolone (Nilevar)]]
 *[[NovoTTF-100A system (Optune)]]
-*[[NOX-A12]] '''in clinical trials'''
 ==O==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[Obinutuzumab (Gazyva)]]
 *[[Octreotide (Sandostatin)]]
 *[[Octreotide LAR (Sandostatin LAR)]]
 *[[Ofatumumab (Arzerra)]]
-*[[Olanzapine (Zyprexa)]]
 *[[Olaparib (Lynparza)]]
-*[[Olaratumab (Lartruvo)]]
+*[[Olutasidenib (Rezlidhia)]]
+*[[Olverembatinib (HQP-1351)]]
 *[[Omacetaxine (Synribo)]]
-*[[Omeprazole (Prilosec)]]
-*[[Onartuzumab (MetMAb)]] '''in clinical trials'''
-*[[Ondansetron (Zofran)]]
-*[[Oprelvekin (Neumega)]]
-*[[Oprozomib (ONX 0912)]] '''in clinical trials'''
-*[[Orteronel (TAK-700)]] '''in clinical trials'''
 *[[Osimertinib (Tagrisso)]]
-*[[Otlertuzumab (TRU-016)]] '''in clinical trials'''
 *[[Oxaliplatin (Eloxatin)]]
 ==P==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[Paclitaxel (Taxol)]]
 *[[Paclitaxel, nanoparticle albumin-bound (Abraxane)]]
 *[[Paclitaxel, polymeric micelle-bound (Genexol-PM)]]
-*[[Pacritinib (SB1518)]] '''in clinical trials'''
+*[[Pacritinib (Vonjo)]]
+*[[Padeliporfin (Tookad)]]
 *[[Palbociclib (Ibrance)]]
-*[[Palonosetron (Aloxi)]]
-*[[Pamidronate (Aredia)]]
 *[[Panitumumab (Vectibix)]]
 *[[Panobinostat (Farydak)]]
-*[[Pantoprazole (Protonix)]]
 *[[Pazopanib (Votrient)]]
 *[[Pegaspargase (Oncaspar)]]
-*[[Pegfilgrastim (Neulasta)]]
-*[[Pegfilgrastim-jmdb (Fulphila)]] '''FDA approved 6/4/2018'''
 *[[Peginterferon alfa-2a (Pegasys)]]
 *[[Peginterferon alfa-2b (Sylatron)]]
+*[[Pegylated liposomal doxorubicin (Doxil)]]
 *[[Pembrolizumab (Keytruda)]]
 *[[Pemetrexed (Alimta)]]
-*[[Pentamidine (Nebupent)]]
+*[[Pemigatinib (Pemazyre)]]
+*[[Penpulimab (Anniko)]]
 *[[Pentostatin (Nipent)]]
-*[[Pentraxin 2 (PRM-151)]] '''in clinical trials'''
-*[[Perifosine (KRX-0401)]] '''in clinical trials'''
 *[[Pertuzumab (Perjeta)]]
-*[[Phosphomannopentaose sulfate (PI-88)]] '''in clinical trials'''
+*[[Pertuzumab and Trastuzumab hyaluronidase (Phesgo)]]
-*[[Phytonadione (Vitamin K)]]
+*[[Pexidartinib (Turalio)]]
-*[[Pictilisib (GDC-0941)]] '''in clinical trials'''
+*[[Pipobroman (Vercyte)]]
-*[[Pidilizumab (CT-011)]] '''in clinical trials'''
-*[[Pinatuzumab vedotin (DCDT2980S)]] '''in clinical trials'''
 *[[Pirarubicin (THP)]]
+*[[Pirtobrutinib (Jaypirca)]] '''FDA approved 2023-01-27'''
 *[[Pixantrone (Pixuvri)]]
-*[[Plerixafor (Mozobil)]]
+*[[Polatuzumab vedotin (Polivy)]]
-*[[Plicamycin (Mithracin)]]
-*[[Plinabulin (NPI-2358)]] '''in clinical trials'''
-*[[Polatuzumab vedotin (DCDS4501A)]] '''in clinical trials'''
 *[[Pomalidomide (Pomalyst)]]
 *[[Ponatinib (Iclusig)]]
 *[[Porfimer (Photofrin)]]
-*[[Pracinostat (SB939)]]
 *[[Pralatrexate (Folotyn)]]
-*[[Prasugrel (Effient)]]
+*[[Pralsetinib (Gavreto)]]
-*[[Pravastatin (Pravachol)]]
 *[[Prednisone (Sterapred)]]
 *[[Prednisolone (Millipred)]]
 *[[Procarbazine (Matulane)]]
-*[[Prochlorperazine (Compazine)]]
+*[[Pyrotinib (Irene)]]
-*[[Promethazine (Phenergan)]]
-*[[Protamine sulfate]]
-*[[Prothrombin Complex Concentrate, human]]
 ==Q==
-*[[Quinine (Qualaquin)]]
+*[[Quizartinib (Vanflyta)]]
-*[[Quisinostat (JNJ-26481585)]] '''in clinical trials'''
-*[[Quizartinib (AC220)]] '''in clinical trials'''
 ==R==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Racotumomab (Vaxira)]]
-|-
+*[[Radium-223 (Xofigo)]]
-|[[#top|back to top]]
-|}
-*[[Rabeprazole (Aciphex)]]
-*[[Radium Ra 223 (Xofigo)]]
 *[[Radotinib (Supect)]]
-*[[Raloxifene (Evista)]]
 *[[Raltitrexed (Tomudex)]]
-*[[Ramosetron (Iribo)]]
 *[[Ramucirumab (Cyramza)]]
-*[[Ranitidine (Zantac)]]
+*[[Ranimustine (Cymerin)]]
-*[[Rasburicase (Elitek)]]
+*[[Ravulizumab (Ultomiris)]]
+*[[Realgar-Indigo naturalis formulation]]
 *[[Regorafenib (Stivarga)]]
-*[[Reovirus (Reolysin)]] '''in clinical trials'''
+*[[Relugolix (Orgovyx)]]
-*[[Retaspimycin (IPI-504)]] '''in clinical trials'''
+*[[Repotrectinib (Augtyro)]] '''FDA approved 2023-11-15'''
-*[[Rho(D) immune globulin (RhoGAM)]]
+*[[Retifanlimab (Zynyz)]] '''FDA approved 2023-03-22'''
-*[[Ribociclib (Kisqali)]] '''FDA approved 3/13/2017'''
+*[[Ribociclib (Kisqali)]]
-*[[Ricolinostat (ACY-1215, Rocilinostat)]] '''in clinical trials'''
+*[[Ripretinib (Qinlock)]]
-*[[Ridaforolimus (AP23573)]] '''in clinical trials'''
-*[[Rilotumumab (AMG 102)]] '''in clinical trials'''
-*[[Risedronate (Actonel)]]
 *[[Rituximab (Rituxan)]]
-*[[Rituximab and hyaluronidase human (Rituximab Hycela)]] '''FDA approved 6/22/2017'''
+**[[Rituximab-abbs (Truxima)]]
-*[[Rivaroxaban (Xarelto)]]
+**[[Rituximab-arrx (Riabni)]]
-*[[Rociletinib (CO-1686)]] '''in clinical trials'''
+**[[Rituximab-pvvr (Ruxience)]]
-*[[Rolapitant (Varubi)]]
+**[[Rituximab-blit (Blitzima)]]
+**[[Rituximab-rite (Ritemvia)]]
+**[[Rituximab-rixa (Rixathon)]]
+**[[Rituximab-rixi (Riximyo)]]
+*[[Rituximab and hyaluronidase human (Rituxan Hycela)]]
 *[[Romidepsin (Istodax)]]
-*[[Romiplostim (Nplate)]]
+*[[Ropeginterferon alfa-2b (Besremi)]]
-*[[Ropeginterferon alfa-2b (AOP2014)]] '''in clinical trials'''
 *[[Rucaparib (Rubraca)]]
 *[[Ruxolitinib (Jakafi)]]
 ==S==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
+*[[Sacituzumab govitecan (Trodelvy)]]
-|}
-*[[Sacituzumab govitecan (IMMU-132)]] '''in clinical trials'''
 *[[Samarium-153 (Quadramet)]]
-*[[Sapacitabine (CS-682)]] '''in clinical trials'''
+*[[Selinexor (Xpovio)]]
-*[[SAR650984]] '''in clinical trials'''
+*[[Selpercatinib (Retevmo)]]
-*[[Sargramostim (Leukine)]]
+*[[Selumetinib (Koselugo)]]
-*[[Scopolamine (Scopoderm)]]
+*[[Serplulimab (Hansizhuang)]]
-*[[Seliciclib (CYC202)]] '''in clinical trials'''
+*[[Sintilimab (Tyvyt)]]
-*[[Selinexor (KPT-330)]] '''in clinical trials'''
-*[[Selumetinib (AZD6244)]] '''in clinical trials'''
-*[[Semuloparin (AVE5026)]] '''in clinical trials'''
-*[[Sennosides (Senna)]]
-*[[SGN-CD19A]] '''in clinical trials'''
-*[[Siltuximab (Sylvant)]]
 *[[Sipuleucel-T (Provenge)]]
-*[[Sirolimus (Rapamune)]]
+*[[Sirolimus protein-bound particles (Fyarro)]]
-*[[SL-401]] '''in clinical trials'''
 *[[Sonidegib (Odomzo)]]
 *[[Sorafenib (Nexavar)]]
+*[[Sotorasib (Lumakras)]]
+*[[Stilbamidine]]
 *[[Streptozocin (Zanosar)]]
+*[[Strontium-89 (Metastron)]]
+*[[Sugemalimab (Cejemly)]]
 *[[Sunitinib (Sutent)]]
+*[[Suramin (Antrypol)]]
 ==T==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Tabelecleucel (Ebvallo)]]
-|-
+*[[Tafasitamab (Monjuvi)]]
-|[[#top|back to top]]
+*[[Tagraxofusp (Elzonris)]]
-|}
+*[[Talazoparib (Talzenna)]]
-*[[Tabalumab (LY2127399)]] '''in clinical trials'''
-*[[Tacrolimus (Prograf)]]
-*[[TAK-228 (MLN0128)]] '''in clinical trials'''
-*[[Talazoparib (BMN-673)]] '''in clinical trials'''
 *[[Talimogene laherparepvec (Imlygic)]]
-*[[Tamibarotene (Amnoid)]] '''in clinical trials'''
+*[[Taloporfin (Laserphyrin)]]
+*[[Talquetamab (Talvey)]] '''FDA approved 2023-08-09'''
+*[[Tamibarotene (Amnoid)]]
 *[[Tamoxifen (Nolvadex)]]
-*[[Tazemetostat (E7438)]] '''in clinical trials'''
+*[[Tarlatamab (Imdelltra)]] '''FDA approved 2024-05-16'''
-*[[Tbo-filgrastim (Granix)]]
+*[[Tasonermin (Beromun)]]
+*[[Tazemetostat (Tazverik)]]
+*[[Tebentafusp (Kimmtrak)]]
+*[[Teclistamab (Tecvayli)]]
 *[[Tegafur and uracil (UFT)]]
-*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]] '''in clinical trials'''
+*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]]
-*[[Telotristat (Xermelo)]] '''FDA approved 2/28/2017'''
+*[[Temoporfin (Foscan)]]
 *[[Temozolomide (Temodar)]]
 *[[Temsirolimus (Torisel)]]
 *[[Teniposide (Vumon)]]
-*[[Tesetaxel (DJ-927)]] '''in clinical trials'''
+*[[Tepotinib (Tepmetko)]]
 *[[Thalidomide (Thalomid)]]
 *[[Thioguanine (Tabloid)]]
 *[[Thiotepa (Tepadina)]]
 *[[Thiotepa (Thioplex)]]
-*[[Ticagrelor (Brilinta)]]
+*[[Tirabrutinib (Velexbru)]]
-*[[Ticlodipine (Ticlid)]]
+*[[Tisagenlecleucel (Kymriah)]]
-*[[Tigatuzumab (CS-1008)]] '''in clinical trials'''
+*[[Tisotumab vedotin (Tivdak)]]
-*[[Tinzaparin (Innohep)]]
-*[[Tipifarnib (Zarnestra)]] '''in clinical trials'''
-*[[Tirabrutinib (GS-4059)]] '''in clinical trials'''
-*[[Tirofiban (Aggrastat)]]
-*[[Tisagenlecleucel (Kymriah)]] '''FDA approved 8/30/17'''
-*[[Tivantinib (ARQ 197)]] '''in clinical trials'''
-*[[Tivozanib (AV-951)]] '''in clinical trials'''
-*[[Tocilizumab (Actemra)]]
-*[[Tofacitinib (Xeljanz)]]
 *[[Topotecan (Hycamtin)]]
 *[[Toremifene (Fareston)]]
-*[[Tosedostat (CHR-2797)]] '''in clinical trials'''
+*[[Toripalimab (Loqtorzi)]] '''FDA approved 2023-10-27'''
-*[[Tositumomab & I-131 (Bexxar)]]
+*[[Tositumomab and I-131 (Bexxar)]]
+*[[Tovorafenib (Ojemda)]] '''FDA approved 2024-04-23'''
 *[[Trabectedin (Yondelis)]]
 *[[Trametinib (Mekinist)]]
-*[[Tranexamic acid (Cyklokapron)]]
 *[[Trastuzumab (Herceptin)]]
-*[[Trastuzumab-dkst (Ogivri)]] '''FDA approved 12/1/2017'''
+**[[Trastuzumab-anns (Kanjinti)]]
-*[[Trebananib (AMG 386)]] '''in clinical trials'''
+**[[Trastuzumab-dkst (Ogivri)]]
-*[[Tremelimumab (ticilimumab)]] '''in clinical trials'''
+**[[Trastuzumab-dttb (Ontruzant)]]
-*[[All-trans retinoic acid (ATRA)]]
+**[[Trastuzumab-herw (Herwenda)]]
+**[[Trastuzumab-pkrb (Herzuma)]]
+**[[Trastuzumab-qyyp (Trazimera)]]
+**[[Trastuzumab-strf (Hercessi)]] '''FDA approved 2024-04-29'''
+**[[Trastuzumab-zerc (Zercepac)]]
+*[[Trastuzumab and hyaluronidase (Herceptin Hylecta)]]
+*[[Trastuzumab deruxtecan (Enhertu)]]
+*[[Trastuzumab emtansine (Kadcyla)]]
+*[[Tremelimumab (Imjudo)]]
+*[[Treosulfan (Ovastat)]]
 *[[Trifluridine and tipiracil (Lonsurf)]]
-*[[Trimethoprim/Sulfamethoxazole (Bactrim DS)]]
+*[[Trilostane (Vetoryl)]]
+*[[Trimetrexate (Neutrexin)]]
 *[[Triptorelin (Trelstar LA)]]
-*[[Tropisetron (Navoban)]]
+*[[Trofosfamide (Ixoten)]]
+*[[Tucatinib (Tukysa)]]
 ==U==
-*[[Ublituximab (TG-1101)]] '''in clinical trials'''
+*[[Ublituximab (Briumvi)]] '''FDA approved 2023-01-06'''
-*[[Umbralisib (TGR-1202)]] '''in clinical trials'''
-*[[Uridine triacetate (Vistogard)]]
 ==V==
-{| class="wikitable" style="float:right; margin-left: 5px;"
+*[[Valemetostat (Ezharmia)]]
-|-
-|[[#top|back to top]]
-|}
-*[[Vadastuximab talirine (SGN-CD33A)]] '''in clinical trials'''
-*[[Valacyclovir (Valtrex)]]
-*[[Valganciclovir (Valcyte)]]
-*[[Valproate (Depakote)]]
 *[[Valrubicin (Valstar)]]
 *[[Vandetanib (Caprelsa)]]
-*[[Varlilumab (CDX-1127)]] '''in clinical trials'''
-*[[Veliparib (ABT-888)]] '''in clinical trials'''
-*[[Veltuzumab (hA20)]] '''in clinical trials'''
 *[[Vemurafenib (Zelboraf)]]
-*[[Venetoclax (Venclexta)]] '''FDA approved 4/11/16'''
+*[[Venetoclax (Venclexta)]]
 *[[Vinblastine (Velban)]]
 *[[Vincristine (Oncovin)]]
-*[[Vincristine liposomal (Marqibo)]]
 *[[Vindesine (Eldisine)]]
 *[[Vinflunine (Javlor)]]
 *[[Vinorelbine (Navelbine)]]
 *[[Vismodegib (Erivedge)]]
-*[[Volasertib (BI 6727)]]
+*[[Vorinostat (Zolinza)]]
+*[[Voxelotor (Oxbryta)]]
+==Z==
+*[[Zanubrutinib (Brukinsa)]]
+*[[Zimberelimab (Yu Duo)]]
+*[[Ziv-aflibercept (Zaltrap)]]
+**[[Aflibercept-jbvf (Yesafili)]] '''FDA approved 2024-05'''
+**[[Aflibercept-yszy (Opuviz)]] '''FDA approved 2024-05'''
+=Discontinued antineoplastics=
+''This section contains drugs that have had at least one formal approval in any domain (FDA, EMA, etc), but are no longer on the market. Note that it is possible that these drugs continue to be available in some limited way, such as through compassionate use programs.
+==A==
+*[[Aminopterin]]
+*[[Asparaginase (Elspar)]]
+==D==
+*[[Daunorubicin liposomal (DaunoXome)]]
+*[[Denileukin diftitox (Ontak)]]
+*[[Diethylstilbestrol (DES)]]
+==E==
+*[[Edrecolomab (Panorex)]]
+*[[Ethinylestradiol]]
+==F==
+*[[Floxuridine (FUDR)]]
+*[[Fluoxymesterone (Halotestin)]]
+*[[Formestane (Lentaron)]]
+==L==
+*[[Levamisole (Ergamisol)]]
+==M==
+*[[Melphalan flufenamide (Pepaxto)]]
+==O==
+*[[Olaratumab (Lartruvo)]]
+==P==
+*[[Paclitaxel poliglumex (Opaxio)]]
+*[[Plicamycin (Mithracin)]]
+*[[Polyestradiol phosphate (Estradurin)]]
+==S==
+*[[Semustine (MeCCNU)]]
+==T==
+*[[Testolactone (Teslac)]]
+*[[Triethylenemelamine (Tretamine)]]
+==U==
+*[[Umbralisib (Ukoniq)]]
+*[[Uracil mustard]]
+*[[Urethane]]
+==V==
+*[[Vincristine liposomal (Marqibo)]]
+=Investigational antineoplastics=
+''This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.''
+==A==
+*[[Abexinostat (PCI-24781)]]
+*[[Actinium Ac 225 lintuzumab (Actimab-A)]]
+*[[Adavosertib (MK-1775)]]
+*[[Adebrelimab (SHR-1316)]]
+*[[Adenovirus-interferon-γ (TG-1042)]]
+*[[Afamitresgene Autoleucel (ADP-A2M4)]]
+*[[Afuresertib (GSK-2110183)]]
+*[[Agatolimod (PF-3512676)]]
+*[[Alisertib (MLN-8237)]]
+*[[Amatuximab (MORAb-009)]]
+*[[Amonafide (Quinamed)]]
+*[[Apocept (APG-101)]]
+*[[Astuprotimut-R (GSK-1572932A)]]
+==B==
+*[[Barasertib (AZD-1152)]]
+*[[Bavituximab (PGN-401)]]
+*[[Befotertinib (D-0316)]]
+*[[Belagenpumatucel-L (Lucanix)]]
+*[[BE-CAR7]]
+*[[BHQ-880]]
+*[[Birtamimab (NEOD-001)]]
+*[[BL22 immunotoxin (CAT-3888)]]
+*[[Buparlisib (BKM-120)]]
+==C==
+*[[CARv3-TEAM-E T-cells]]
+*[[Catumaxomab (Removab)]] '''in US clinical trials'''
+*[[Cediranib (Recentin)]]
+*[[Cixutumumab (IMC-A12)]]
+*[[Coltuximab ravtansine (SAR-3419)]]
+*[[Crenolanib (CP-868,596)]]
+*[[Custirsen (OGX-011)]]
+==D==
+*[[Dalpiciclib (SHR-6390)]]
+*[[Danicopan (ALXN-2040)]]
+*[[Datopotamab deruxtecan (DS-1062)]]
+*[[Denintuzumab mafodotin (SGN-CD19A)]]
+*[[Dinaciclib (SCH-727965)]]
+*[[Divarasib (GDC-6036)]]
+*[[Discodermolide (XAA-296)]]
+*[[DMUC-5754A]]
+*[[Dovitinib (TKI-258)]]
+==E==
+*[[Emepepimut-S (Stimuvax)]]
+*[[Eluvixtamab (AMG-330)]]
+*[[Entinostat (SNDX-275)]]
+*[[Entospletinib (GS-9973)]]
+*[[Envonalkib (TQ-B3139)]]
+*[[Epratuzumab (LymphoCide)]]
+*[[Etirinotecan pegol (NKTR-102)]]
+==F==
+*[[Farletuzumab (MORAb-003)]]
+*[[Figitumumab (CP-751,871)]]
+*[[Filanesib (ARRY-520)]]
+==G==
+*[[G207]]
+*[[Galeterone (TOK-001)]]
+*[[Galunisertib (LY-2157299)]]
+*[[Ganetespib (STA-9090)]]
+*[[Ganitumab (AMG-479)]]
+*[[GD2-CART01]]
+*[[Gemcitabine elaidate (CP-4126)]]
+*[[Glembatumumab vedotin (CDX-011)]]
+*[[Guadecitabine (SGI-110)]]
+==H==
+*[[HER2 peptide vaccine (AE37)]]
+*[[Hu5F9-G4]]
+==I==
+*[[Idasanutlin (RG-7388)]]
+*[[IMA-901]]
+*[[Indatuximab ravtansine (BT-062)]]
+*[[Ipatasertib (GDC-0068)]]
+*[[IPH-2101]]
+==J==
+*[[JCAR015]]
+==L==
+*[[Lapuleucel-T (DN24-02)]]
+*[[Lestaurtinib (CEP-701)]]
+*[[Linifanib (ABT-869)]]
+*[[Linsitinib (OSI-906)]]
+*[[Lorvotuzumab mertansine (BB-10901)]]
+*[[Lutetium-177-PSMA-617]]
+*[[LY-3023414]]
+==M==
+*[[Magrolimab (Hu5F9-G4)]]
+*[[Mapatumumab (HGS-ETR1)]]
+*[[Masitinib (AB-1010)]]
+*[[MCARH-109]]
+*[[Mezigdomide (BMS-986348)]]
+*[[Milataxel (TL-139)]]
+*[[MK-2206]]
+*[[Mocetinostat (MGCD-0103)]]
+*[[Motesanib (AMG-706)]]
+==N==
+*[[Nolatrexed (Thymitaq)]]
+==O==
+*[[Oblimersen (Genasense)]]
+*[[Olaptesed pegol (NOX-A12)]]
+*[[Onartuzumab (MetMAb)]]
+*[[Oprozomib (ONX-0912)]]
+*[[Orteronel (TAK-700)]]
+*[[Osocimab (BAY-1213790)]]
+*[[Otlertuzumab (TRU-016)]]
+==P==
+*[[Patritumab deruxtecan (U3-1402)]]
+*[[Pentraxin 2 (PRM-151)]]
+*[[Perifosine (KRX-0401)]]
+*[[Phosphomannopentaose sulfate (PI-88)]]
+*[[Pictilisib (GDC-0941)]]
+*[[Pidilizumab (CT-011)]]
+*[[Pimitespib (TAS-116)]]
+*[[Pinatuzumab vedotin (DCDT-2980S)]]
+*[[Plinabulin (NPI-2358)]]
+*[[Pracinostat (SB-939)]]
+==Q==
+*[[Quisinostat (JNJ-26481585)]]
+==R==
+*[[Rebimastat (BMS-275291)]]
+*[[Refametinib (BAY-869766)]]
+*[[Reovirus (Reolysin)]]
+*[[Retaspimycin (IPI-504)]]
+*[[Revumenib (SNDX-5613)]]
+*[[Rezvilutamide (SHR-3680)]]
+*[[Ricolinostat (ACY-1215)]]
+*[[Ridaforolimus (AP-23573)]]
+*[[Rilotumumab (AMG-102)]]
+*[[Ripertamab (SCT-400)]]
+*[[Rociletinib (CO-1686)]]
+==S==
+*[[Sapacitabine (CS-682)]]
+*[[Sapanisertib (MLN-0128)]]
+*[[Seliciclib (CYC-202)]]
+*[[Semuloparin (AVE-5026)]]
+*[[Spebrutinib (CC-292)]]
+*[[Surufatinib (HMPL-012)]]
+==T==
+*[[Tabalumab (LY-2127399)]]
+*[[Tasadenoturev (DNX-2401)]]
+*[[Telisotuzumab vedotin (ABBV-399)]]
+*[[Tertomotide (GV-1001)]]
+*[[Tesetaxel (DJ-927)]]
+*[[Tesevatinib (XL-647)]]
+*[[Tigatuzumab (CS-1008)]]
+*[[Tipifarnib (Zarnestra)]]
+*[[Tirapazamine (Tirazone)]]
+*[[Tislelizumab (Baizean)]]
+*[[Tivantinib (ARQ-197)]]
+*[[Tivozanib (AV-951)]]
+*[[Tosedostat (CHR-2797)]]
+*[[Trebananib (AMG-386)]]
+*[[Tusamitamab ravtansine (SAR-408701)]]
+==U==
+*[[UCART19]]
+==V==
+*[[Vadastuximab talirine (SGN-CD33A)]]
+*[[Vadimezan (AS-A404)]]
+*[[Varlilumab (CDX-1127)]]
+*[[Veliparib (ABT-888)]]
+*[[Veltuzumab (hA20)]]
+*[[Volasertib (BI-6727)]]
+*[[Vorasidenib (AG-881)]]
+*[[Vorolanib (CM-082)]]
+*[[Vosaroxin (SNS-595)]]
+*[[Voxtalisib (XL-765)]]
+==Z==
+*[[Zandelisib (ME-401)]]
+*[[Zolbetuximab (IMAB-362)]]
+=Supportive and other medications=
+''This section contains supportive drugs that are either approved or investigational. Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound.''
+==A==
+*[[Abciximab (ReoPro)]]
+*[[Acetaminophen (Tylenol)]]
+*[[Acetazolamide (Diamox)]]
+*[[Acyclovir (Zovirax)]]
+*[[ADAMTS13, recombinant (Adzynma)]]
+*[[Alendronate (Fosamax)]]
+*[[Alizapride (Litican)]]
+*[[Allopurinol (Zyloprim)]]
+*[[Alprazolam (Xanax)]]
+*[[Aminocaproic acid (Amicar)]]
+*[[Amoxicillin]]
+*[[Anagrelide (Agrylin)]]
+*[[Andexanet alfa (Andexxa)]]
+*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
+*[[Antithrombin III (human and recombinant)]]
+*[[Antithymocyte globulin, horse ATG (Atgam)]]
+*[[Antithymocyte globulin, rabbit ATG (Grafalon)]]
+*[[Antithymocyte globulin, rabbit ATG (Thymoglobulin)]]
+*[[Apixaban (Eliquis)]]
+*[[Aprepitant (Emend)]]
+*[[Argatroban (Acova)]]
+*[[Aripiprazole (Abilify)]]
+*[[Ascorbic acid (Vitamin C)]]
+*[[Aspirin]]
+*[[Aspirin and dipyridamole (Aggrenox)]]
+*[[Atropine (Atropen)]]
+*[[Atovaquone (Mepron)]]
+*[[Avatrombopag (Doptelet)]]
+*[[Azathioprine (Imuran)]]
+==B==
+*[[Betibeglogene autotemcel (Zynteglo)]]
+*[[Betrixaban (Bevyxxa)]]
+*[[Bismuth subsalicylate (Pepto-Bismol)]]
+*[[Bivalirudin (Angiomax)]]
+==C==
+*[[Cangrelor (Kengreal)]]
+*[[Calcium phosphate rinse (Caphosol)]]
+*[[Caspofungin (Cancidas)]]
+*[[Cetirizine (Zyrtec)]]
+*[[Chlorpheniramine (Chlor-Trimeton)]]
+*[[Cilostazol (Pletal)]]
+*[[Cimetidine (Tagamet)]]
+*[[Ciprofloxacin (Cipro)]]
+*[[Clarithromycin (Biaxin)]]
+*[[Clemastine (Tavist)]]
+*[[Clodronate (Bonefos)]]
+*[[Clopidogrel (Plavix)]]
+*[[Concizumab (Alhemo)]]
+*[[Crizanlizumab (Adakveo)]]
+*[[Cyanocobalamin (Vitamin B12)]]
+*[[Cyclosporine]]
+*[[Cytomegalovirus Immune Globulin (Cytogam)]]
+==D==
+*[[Dabigatran (Pradaxa)]]
+*[[Dalteparin (Fragmin)]]
+*[[Danazol (Danocrine)]]
+*[[Dapsone (Aczone)]]
+*[[Darbepoetin alfa (Aranesp)]]
+*[[Deferasirox (Exjade)]]
+*[[Deferasirox (Jadenu)]]
+*[[Deferiprone (Ferriprox)]]
+*[[Deferoxamine (Desferal)]]
+*[[Defibrotide (Defitelio)]]
+*[[Denosumab (Xgeva)]]
+**[[Denosumab-bddz (Wyost)]]
+*[[Desmopressin (DDAVP)]]
+*[[Dexchlorpheniramine (Polaramine)]]
+*[[Dexrazoxane (Zinecard)]]
+*[[Diphenhydramine (Benadryl)]]
+*[[Dipyridamole (Persantine)]]
+*[[Docusate (Colace)]]
+*[[Dolasetron (Anzemet)]]
+*[[Domperidone (Motilium)]]
+*[[Doxycycline]]
+*[[Dronabinol (Marinol)]]
+==E==
+*[[Eculizumab (Soliris)]]
+**[[Eculizumab-beke (Bekemv)]]
+**[[Eculizumab-epys (Epysqli)]]
+*[[Edoxaban (Savaysa)]]
+*[[Efanesoctocog alfa (Altuviiio)]]
+*[[Eflapegrastim (Rolvedon)]]
+*[[Eltrombopag (Promacta)]]
+*[[Emicizumab (Hemlibra)]]
+*[[Enoxaparin (Lovenox)]]
+**[[Enoxaparin-inhi (Inhixa)]]
+*[[Epoetin alfa (Procrit)]]
+**[[Epoetin alfa-epbx (Retacrit)]]
+**[[Epoetin alfa-abse (Abseamed)]]
+**[[Epoetin alfa-bino (Binocrit)]]
+**[[Epoetin alfa-hexa (Epoetin Alfa Hexal)]]
+*[[Epoetin theta (Biopoin)]]
+*[[Epoetin zeta (Eprex)]]
+**[[Epoetin zeta-reta (Retacrit)]]
+**[[Epoetin zeta-sila (Silapo)]]
+*[[Eptifibatide (Integrilin)]]
+*[[Etranacogene dezaparvovec (Hemgenix)]]
+*[[Exagamglogene autotemcel (Casgevy)]] '''FDA approved on 2023-12-08'''
+==F==
+*[[Factor VIIa, recombinant (NovoSeven RT)]]
+*[[Factor VIII, human]]
+*[[Factor VIII, recombinant]]
+*[[Factor IX, human]]
+*[[Factor IX, recombinant]]
+*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
+*[[Factor X, human (Coagadex)]]
+*[[Factor XIII concentrate, human (Corifact)]]
+*[[Famciclovir (Famvir)]]
+*[[Famotidine (Pepcid)]]
+*[[Ferric carboxymaltose (Injectafer)]]
+*[[Ferric derisomaltose (Monoferric)]]
+*[[Ferric gluconate (Ferrlecit)]]
+*[[Ferrous sulfate (Feosol)]]
+*[[Ferumoxytol (Feraheme)]]
+*[[Fibrinogen concentrate, human (RiaSTAP)]]
+*[[Filgrastim (Neupogen)]]
+**[[Filgrastim-aafi (Nivestym)]]
+**[[Filgrastim-ayow (Releuko)]]
+**[[Filgrastim-sndz (Zarxio)]]
+**[[Filgrastim-acco (Accofil)]]
+**[[Filgrastim-hexa (Filgrastim Hexal)]]
+**[[Filgrastim-gras (Grastofil)]]
+**[[Filgrastim-rati (Ratiograstim)]]
+**[[Filgrastim-teva (Tevagrastim)]]
+*[[Finasteride (Proscar)]]
+*[[Fitusiran (ALN-AT3SC)]]
+*[[Fluconazole (Diflucan)]]
+*[[Folic acid (Folate)]]
+*[[Fondaparinux (Arixtra)]]
+*[[Fosaprepitant (Emend for Injection)]]
+*[[Fosnetupitant (Arokaris)]]
+*[[Furosemide (Lasix)]]
+==G==
+*[[Glucarpidase (Voraxaze)]]
+*[[Granisetron]]
+==H==
+*[[Haloperidol (Haldol)]]
+*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
+==I==
+*[[Ibandronate (Boniva)]]
+*[[Idarucizumab (Praxbind)]]
+*[[Indomethacin (Indocin)]]
+*[[Iptacopan (Fabhalta)]] '''FDA approved 2023-12-05'''
+*[[Iron dextran (INFeD)]]
+*[[Iron sucrose (Venofer)]]
+*[[Itraconazole (Sporanox)]]
+==L==
+*[[Lactulose]]
+*[[Lamivudine (Epivir)]]
+*[[Lansoprazole (Prevacid)]]
+*[[Lenograstim (Granocyte)]]
+*[[Lepirudin (Refludan)]] '''discontinued'''
+*[[Letermovir (Prevymis)]]
+*[[Levofloxacin (Levaquin)]]
+*[[L-glutamine (Endari)]]
+*[[Lipefilgrastim (Lonquex)]]
+*[[Loperamide (Imodium)]]
+*[[Lorazepam (Ativan)]]
+*[[Lovotibeglogene autotemcel (Lyfgenia)]] '''FDA approved on 2023-12-08'''
+*[[Luspatercept (Reblozyl)]]
+*[[Lusutrombopag (Mulpleta)]]
+==M==
+*[[Mannitol]]
+*[[Meperidine (Demerol)]]
+*[[Mesna (Mesnex)]]
+*[[Methyltesterone (Android)]]
+*[[Metoclopramide (Reglan)]]
+*[[Mitapivat (Pyrukynd)]]
+*[[Motixafortide (Aphexda)]] '''FDA approved 2023-09'''
+*[[Mycophenolate mofetil (CellCept)]]
+==N==
+*[[Nabilone (Cesamet)]]
+*[[Netupitant and palonosetron (Akynzeo)]]
+*[[Nonacog beta pegol (Refixia)]]
+==O==
+*[[Olanzapine (Zyprexa)]]
+*[[Omeprazole (Prilosec)]]
+*[[Omidubicel (Omisirge)]] '''FDA approved 2023-04-17'''
+*[[Ondansetron (Zofran)]]
+*[[Oprelvekin (Neumega)]]
+==P==
+*[[Palifermin (Kepivance)]]
+*[[Palonosetron (Aloxi)]]
+*[[Pamidronate (Aredia)]]
+*[[Pantoprazole (Protonix)]]
+*[[Pegfilgrastim (Neulasta)]]
+**[[Pegfilgrastim-apgf (Nyvepria)]]
+**[[Pegfilgrastim-bmez (Ziextenzo)]]
+**[[Pegfilgrastim-cbqv (Udenyca)]]
+**[[Pegfilgrastim-fpgk (Stimufend)]]
+**[[Pegfilgrastim-jmdb (Fulphila)]]
+**[[Pegfilgrastim-cegf (Cegfila)]]
+**[[Pegfilgrastim-gras (Grasustek)]]
+**[[Pegfilgrastim-pbbk (Fylnetra)]]
+**[[Pegfilgrastim-pelg (Pelgraz)]]
+**[[Pegfilgrastim-pelm (Pelmeg)]]
+**[[Pegfilgrastim-stim (Stimufend)]]
+*[[Penicillin V]]
+*[[Pentamidine (Nebupent)]]
+*[[Phenytoin (Dilantin)]]
+*[[Phytonadione (Vitamin K)]]
+*[[Plerixafor (Mozobil)]]
+*[[Prasugrel (Effient)]]
+*[[Pravastatin (Pravachol)]]
+*[[Prochlorperazine (Compazine)]]
+*[[Promethazine (Phenergan)]]
+*[[Protamine sulfate]]
+*[[Protein C, human (Ceprotin)]]
+*[[Prothrombin Complex Concentrate, human]]
+==Q==
+*[[Quinine (Qualaquin)]]
+==R==
+*[[Rabeprazole (Aciphex)]]
+*[[Raloxifene (Evista)]]
+*[[Ramosetron (Iribo)]]
+*[[Ranitidine (Zantac)]]
+*[[Rasburicase (Elitek)]]
+*[[Remestemcel-L (Prochymal)]]
+*[[Rho(D) immune globulin (RhoGAM)]]
+*[[Rilzabrutinib (PRN-1008)]]
+*[[Risedronate (Actonel)]]
+*[[Rivaroxaban (Xarelto)]]
+*[[Rolapitant (Varubi)]]
+*[[Romiplostim (Nplate)]]
+*[[Rusfertide (PTG-300)]]
+==S==
+*[[Sargramostim (Leukine)]]
+*[[Scopolamine (Scopoderm)]]
+*[[Sennosides (Senna)]]
+*[[Siltuximab (Sylvant)]]
+*[[Sirolimus (Rapamune)]]
+*[[Sodium thiosulfate (Pedmark)]]
+*[[Sutimlimab (Enjaymo)]]
+==T==
+*[[Tacrolimus (Prograf)]]
+*[[Tbo-filgrastim (Granix)]]
+*[[Telotristat (Xermelo)]]
+*[[Ticagrelor (Brilinta)]]
+*[[Ticlopidine (Ticlid)]]
+*[[Tinzaparin (Innohep)]]
+*[[Tirofiban (Aggrastat)]]
+*[[Tocilizumab (Actemra)]]
+**[[Tocilizumab-aazg (Tyenne)]]
+**[[Tocilizumab-bavi (Tofidence)]]
+*[[Tofacitinib (Xeljanz)]]
+*[[Tranexamic acid (Cyklokapron)]]
+*[[Trilaciclib (Cosela)]]
+*[[Trimethoprim-Sulfamethoxazole (Bactrim DS)]]
+*[[Tropisetron (Navoban)]]
+==U==
+*[[Unfractionated heparin (UFH)]]
+*[[Uridine triacetate (Vistogard)]]
+==V==
+*[[Valacyclovir (Valtrex)]]
+*[[Valganciclovir (Valcyte)]]
+*[[Valoctocogene roxaparvovec (AAV5-hFVIII-SQ)]]
+*[[Valproate (Depakote)]]
+*[[Verbrinacogene setparvovec (FLT-180a)]]
 *[[von Willebrand factor and factor VIII complex, human]]
 *[[von Willebrand factor, recombinant]]
+*[[Vonoprazan (Takecab)]]
 *[[Vorapaxar (Zontivity)]]
 *[[Voriconazole (Vfend)]]
-*[[Vorinostat (Zolinza)]]
-*[[Vosaroxin (SNS 595)]] '''in clinical trials'''
-*[[Voxtalisib (XL765)]] '''in clinical trials'''
 ==W==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[Warfarin (Coumadin)]]
-==X==
-*[[XL647]] '''in clinical trials'''
 ==Z==
-*[[Ziv-aflibercept (Zaltrap)]]
 *[[Zoledronic acid (Zometa)]]
 =By Category=
-''Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is still in process so not all of these links are active).''
+''Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is an ongoing process so not all of these links are active or current).''
 ==[[:Category:REMS_program|Drugs in a REMS program]]==
 ==Cytotoxic Chemotherapy==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Alkylating agents|Alkylating agents]]
 *[[:Category:Anthracyclines|Anthracyclines]]
 *[[:Category:Antimetabolites|Antimetabolites]]
-*[[:Category:DNA synthesis inhibitors|DNA synthesis inhibitors]]
+*[[:Category:Human DNA synthesis inhibitors|DNA synthesis inhibitors]]
 *[[:Category:Microtubule inhibitors|Microtubule inhibitors]]
 *[[:Category:Nitrogen mustards|Nitrogen mustards]]
@@ Line 742: / Line 1,116: @@
 ==[[:Category:Kinase inhibitors|Kinase inhibitors]]==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 <div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 *[[:Category:AKT1 inhibitors|AKT1 inhibitors]]
@@ Line 778: / Line 1,149: @@
 </div>
-==[[:Category:Endocrine therapy|Endocrine therapy]]==
+==[[:Category:Endocrine therapeutic|Endocrine therapy]]==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Antiandrogens|Antiandrogens]]
 *[[:Category:Steroid synthesis inhibitors|Steroid synthesis inhibitors]]
@@ Line 795: / Line 1,164: @@
 ==Investigational and Discontinued==
-*[[:Category:Investigational|Investigational]]
-*[[:Category:Discontinued|Discontinued]]
+*[[:Category:Investigational_drugs|Investigational]]
+*[[:Category:Discontinued_drugs|Discontinued]]
 ==Biologics==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Antibody medications|Antibody medications]]
 *[[:Category:Antibody-drug conjugates|Antibody-drug conjugates]]
@@ Line 808: / Line 1,176: @@
 *[[:Category:IL-6 inhibitors|IL-6 inhibitors]]
 *[[:Category:Enzymes|Enzymes]]
-*[[:Category:Immunotherapy|Immunotherapy]]
+*[[:Category:Immunotherapeutic|Immunotherapy]]
 *[[:Category:Immunomodulatory drugs (IMiDs)|Immunomodulatory drugs (IMiDs)]]
 ==Supportive Medications==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Antibacterials|Antibacterials]]
 *[[:Category:Antidiarrheals|Antidiarrheals]]
@@ Line 829: / Line 1,195: @@
 ==[[:Category:Radioactive agents|Radioactive agents]]==
 *[[:Category:Alpha emitters|Alpha emitters]]
 *[[:Category:Radioimmunotherapy|Radioimmunotherapy]]
 ==[[:Category:Hematology medications|Benign Hematology Medications]]==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Anticoagulants|Anticoagulants]]
 **[[:Category:Direct thrombin inhibitors|Direct thrombin inhibitors (DTI)]]
@@ Line 854: / Line 1,219: @@
 ==[[:Category:Hematopoietic growth factors|Hematopoietic Growth Factors]]==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:Erythrocyte growth factors|Erythrocyte growth factors]]
-*[[:Category:Granulocyte colony-stimulating factors
+*[[:Category:Granulocyte colony-stimulating factors|Granulocyte growth factors]]
-|Granulocyte growth factors]]
 *[[:Category:Megakaryocyte growth factors|Megakaryocyte growth factors]]
 ==Miscellaneous==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[:Category:REMS_program|Drugs in a REMS program]]
 *[[:Category:HDAC inhibitors|HDAC inhibitors]]
@@ Line 875: / Line 1,235: @@
 ==Medications by Condition==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 <div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 *[[:Category:B-cell acute lymphoblastic leukemia medications|Acute lymphocytic leukemia medications]]
@@ Line 885: / Line 1,242: @@
 *[[:Category:Anal cancer medications|Anal cancer medications]]
 *[[:Category:Anaplastic large cell lymphoma medications|Anaplastic large cell lymphoma medications]]
-*[[:Category:Basal cell and squamous cell skin cancer medications|Basal cell and squamous cell skin cancer medications]]
 *[[:Category:Bladder cancer medications|Bladder cancer medications]]
 *[[:Category:Bone cancer medications |Bone cancer medications]]
 *[[:Category:Breast cancer medications|Breast cancer medications]]
 *[[:Category:Burkitt lymphoma medications|Burkitt lymphoma medications]]
 *[[:Category:Cancer of unknown primary medications |Cancer of unknown primary medications]]
-*[[:Category:Castleman’s disease medications|Castleman’s disease medications]]
+*[[:Category:Castleman disease medications|Castleman disease medications]]
 *[[:Category:Central nervous system (CNS) cancer medications|Central nervous system (CNS) cancer medications]]
 *[[:Category:CNS lymphoma medications|Central nervous system (CNS) lymphoma medications]]
 *[[:Category:Cervical cancer medications|Cervical cancer medications]]
-*[[:Category:Chronic lymphocytic leukemia (CLL/SLL) medications|Chronic lymphocytic leukemia (CLL/SLL) medications]]
+*[[:Category:Chronic lymphocytic leukemia medications|Chronic lymphocytic leukemia (CLL/SLL) medications]]
-*[[:Category:Chronic myelogenous leukemia medications|Chronic myelogenous leukemia medications]]
+*[[:Category:Chronic myeloid leukemia medications|Chronic myeloid leukemia (CML) medications]]
-*[[:Category:Chronic myelomonocytic leukemia medications|Chronic myelomonocytic leukemia medications]]
+*[[:Category:Chronic myelomonocytic leukemia medications|Chronic myelomonocytic leukemia (CMML) medications]]
 *[[:Category:Colon cancer medications|Colon cancer medications]]
+*[[:Category:Colorectal cancer medications|Colorectal cancer (CRC) medications]]
+*[[:Category:Cutaneous basal cell carcinoma medications|Cutaneous BCC medications]]
+*[[:Category:Cutaneous squamous cell carcinoma medications|Cutaneous SCC medications]]
 *[[:Category:Cutaneous T-cell lymphoma medications|Cutaneous T-cell lymphoma medications]]
 *[[:Category:Diffuse large B-cell lymphoma medications|Diffuse large B-cell lymphoma medications]]
+*[[:Category:Endometrial cancer medications|Endometrial cancer medications]]
 *[[:Category:Esophageal cancer medications|Esophageal cancer medications]]
 *[[:Category:Essential thrombocythemia medications|Essential thrombocythemia medications]]
-*[[:Category:Extranodal NK/T-cell lymphoma, nasal type medications|Extranodal NK/T-cell lymphoma, nasal type lymphoma medications]]
+*[[:Category:Extranodal NK- and T-cell lymphoma, nasal type medications|Extranodal NK/T-cell lymphoma, nasal type lymphoma medications]]
 *[[:Category:Follicular lymphoma medications|Follicular lymphoma medications]]
 *[[:Category:Gastric cancer medications|Gastric cancer medications]]
@@ Line 912: / Line 1,272: @@
 *[[:Category:Hodgkin lymphoma medications|Hodgkin lymphoma medications]]
 *[[:Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications|Hodgkin lymphoma, nodular lymphocyte-predominant medications]]
-*[[:Category:Immune thrombocytopenia (ITP) medications|Immune thrombocytopenic purpura (ITP) medications]]
+*[[:Category:Immune thrombocytopenia medications|Immune thrombocytopenic purpura (ITP) medications]]
 *[[:Category:Light-chain (AL) amyloidosis medications|Light-chain (AL) amyloidosis medications]]
 *[[:Category:Mantle cell lymphoma medications|Mantle cell lymphoma medications]]
 *[[:Category:Marginal zone lymphoma medications|Marginal zone lymphoma medications]]
 *[[:Category:Mediastinal gray-zone lymphoma medications|Mediastinal gray-zone lymphoma medications]]
 *[[:Category:Melanoma medications |Melanoma medications]]
 *[[:Category:Mesothelioma medications|Mesothelioma medications]]
 *[[:Category:Multiple myeloma medications|Multiple myeloma medications]]
 *[[:Category:Myelodysplastic syndrome medications|Myelodysplastic syndrome medications]]
 *[[:Category:Myelofibrosis medications|Myelofibrosis medications]]
-*[[:Category:NK/T-cell lymphoma medications|NK/T-cell lymphoma medications]]
+*[[:Category:NK- and T-cell lymphoma medications|NK/T-cell lymphoma medications]]
 *[[:Category:Non-small cell lung cancer medications|Non-small cell lung cancer medications]]
 *[[:Category:Neuroendocrine tumor medications|Neuroendocrine tumor medications]]
 *[[:Category:Ovarian cancer medications|Ovarian cancer medications]]
 *[[:Category:Pancreatic cancer medications |Pancreatic cancer medications]]
-*[[:Category:Paroxysmal nocturnal hemoglobinuria (PNH) medications|Paroxysmal nocturnal hemoglobinuria (PNH) medications]]
+*[[:Category:Paroxysmal nocturnal hemoglobinuria medications|Paroxysmal nocturnal hemoglobinuria (PNH) medications]]
 *[[:Category:Penile cancer medications |Penile cancer medications]]
 *[[:Category:Peripheral T-cell lymphoma medications|Peripheral T-cell lymphoma medications]]
 *[[:Category:Plasma cell leukemia medications|Plasma cell leukemia medications]]
@@ Line 935: / Line 1,295: @@
 *[[:Category:Prostate cancer medications|Prostate cancer medications]]
 *[[:Category:Rectal cancer medications|Rectal cancer medications]]
-*[[:Category:Renal cancer medications|Renal cancer medications]]
+*[[:Category:Renal cell carcinoma medications|Renal cell carcinoma medications]]
 *[[:Category:Sarcoma medications |Sarcoma medications]]
 *[[:Category:Sickle cell anemia medications|Sickle cell anemia medications]]
 *[[:Category:Small cell lung cancer medications|Small cell lung cancer medications]]
@@ Line 945: / Line 1,305: @@
 *[[:Category:Transformed lymphoma medications|Transformed lymphoma medications]]
 *[[:Category:Transplant medications|Transplant medications]]
-*[[:Category:Uterine cancer medications|Uterine cancer medications]]
 *[[:Category:Waldenström macroglobulinemia medications|Waldenström macroglobulinemia medications]]
 </div>
-==Medications by Route of Administration==
+==[[:Category:Routed medications|Medications by Route of Administration]]==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
+*[[:Category:Intra-arterial medications|Intraarterial (IA) medications]]
-|}
+*[[:Category:Intracavitary medications|Intracavitary medications]]
-*[[:Category:Intra-arterial chemotherapy|Intraarterial (IA) chemotherapy]]
+*[[:Category:Intramuscular medications|Intramuscular (IM) medications]]
-*[[:Category:Intracavitary chemotherapy|Intracavitary chemotherapy]]
+*[[:Category:Intrathecal medications|Intrathecal (IT) medications]]
-*[[:Category:Intramuscular chemotherapy|Intramuscular (IM) chemotherapy]]
+*[[:Category:Intravenous medications|Intravenous (IV) medications]]
-*[[:Category:Intrathecal chemotherapy|Intrathecal (IT) chemotherapy]]
+*[[:Category:Intravesical medications|Intravesicular medications]]
-*[[:Category:Intravenous chemotherapy|Intravenous (IV) chemotherapy]]
+*[[:Category:Oral medications|Oral (PO) medications]]
-*[[:Category:Intravesical chemotherapy|Intravesicular chemotherapy]]
+*[[:Category:Subcutaneous medications|Subcutaneous (SC) medications]]
-*[[:Category:Oral chemotherapy|Oral (PO) chemotherapy]]
-*[[:Category:Subcutaneous chemotherapy|Subcutaneous (SC) chemotherapy]]
+==Medications by FDA Year of Approval==
-==Medications by Year of Approval==
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 <div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 *[[:Category:FDA approved in 1939|FDA approved in 1939]]
@@ Line 1,037: / Line 1,391: @@
 *[[:Category:FDA approved in 2016|FDA approved in 2016]]
 *[[:Category:FDA approved in 2017|FDA approved in 2017]]
-*[[:Category:FDA approved in 2017|FDA approved in 2018]]
+*[[:Category:FDA approved in 2018|FDA approved in 2018]]
+*[[:Category:FDA approved in 2019|FDA approved in 2019]]
+*[[:Category:FDA approved in 2020|FDA approved in 2020]]
+*[[:Category:FDA approved in 2021|FDA approved in 2021]]
+*[[:Category:FDA approved in 2022|FDA approved in 2022]]
+*[[:Category:FDA approved in 2023|FDA approved in 2023]]
+*[[:Category:FDA approved in 2024|FDA approved in 2024]]
 </div>
 =Interesting and Helpful Links=
-{| class="wikitable" style="float:right; margin-left: 5px;"
-|-
-|[[#top|back to top]]
-|}
 *[[Antidepressants and other psychiatric medications in cancer care]]
 *[[Antiemesis|Antiemetic support]]
-*[http://jco.ascopubs.org/content/33/28/3199.full 2015 Update of ASCO Clinical Practice Guideline Recommendations for the Use of WBC Growth Factors]<ref>Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.</ref>
+*[https://doi.org/10.1200/JCO.2012.45.8661 Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline (2013)]
-*[http://ascopubs.org/doi/full/10.1200/JCO.2012.45.8661 Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline (2013)]
+*[https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society (ASCO/ONS) Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology]
-*[http://jco.ascopubs.org/content/30/13/1553.long Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [http://jco.ascopubs.org/content/30/13/1553.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/22473167 PubMed]</ref>
-*[http://ascopubs.org/doi/full/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology]
 *[http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p Chemotherapy Administration Sequence]<ref>Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. [http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p link to original article]</ref> - with chemotherapy sequencing chart
-*[https://onlinelibrary.wiley.com/doi/10.1111/j.1743-7563.2010.01321.x/full The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.] [https://www.ncbi.nlm.nih.gov/pubmed/20887505 PubMed]
+*[https://doi.org/10.1111/j.1743-7563.2010.01321.x The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.] [https://pubmed.ncbi.nlm.nih.gov/20887505/ PubMed]
 *[https://crediblemeds.org/ CredibleMeds.org] - lists of QT-prolonging drugs; requires free registration to see full list
 *[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm FDA drug shortages list]
@@ Line 1,058: / Line 1,414: @@
 *[http://dailymed.nlm.nih.gov/dailymed/index.cfm DailyMed] - a comprehensive NLM portal to all FDA-approved drugs
 *[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ Drugs@FDA] - the main portal into the FDA drug database
-*[http://www.cancer.gov/drugdictionary The NCI Drug Dictionary] - an extensive resource with most antineoplastics (approved and in clinical trials) listed
+*[https://www.cancer.gov/drugdictionary The NCI Drug Dictionary] - an extensive resource with most antineoplastics (approved and in clinical trials) listed
 *[http://blogs.sciencemag.org/pipeline/ In the Pipeline] - a blog from a veteran of the pharmaceutical industry, Derek Lowe. General but much is cancer-relevant. The [http://www.pipeline.corante.com/ old home] of this blog is no longer active.
 *[[Steroid conversions]]
@@ Line 1,066: / Line 1,422: @@
 ==References==
-<references/>
+<references />
 [[Category:General reference pages]]
+[[Category:Clinical pharmacology]]

Difference between revisions of "Drug index"